Bronya J. Keats Research Collaboration Award supports research groups working together on Friedreich's ataxia studies that depend on their combined contributions to advance therapeutic development.
Funder: Friedreich's Ataxia Research Alliance
Due Dates: February 15, 2027 (LOI) | April 15, 2027 (Full application) | August 1, 2027 (Award notice) | September 1–October 1, 2027 (Grant start window)
Funding Amounts: Up to $175,000 USD per year for one or two years; up to one award annually
Summary: Supports collaborative Friedreich’s ataxia research whose goals cannot be achieved by a single research group.
Key Information: Investigators from at least two different institutions must demonstrate that collaboration is essential to success.
The Bronya J. Keats Research Collaboration Award supports Friedreich’s ataxia (FA) research that depends on meaningful collaboration among research groups. Administered by the Friedreich’s Ataxia Research Alliance (FARA), it is part of a competitive research funding program spanning basic research, drug development, and clinical research. Proposals must show why the participating groups’ combined contributions are essential, rather than simply beneficial, to achieving the scientific goals.
Special consideration is given to international collaborations and projects that bring new scientists into the FA research community. The award honors Bronya J. Keats for her academic work studying the GAA triplet repeat mutation in FA and her continued role managing FARA’s grant program. Funded research must align with FARA’s priorities for advancing therapeutic development.